Mauna Kea Technologies

Mauna Kea Technologies
Stock Exchange Euronext Paris
EPS
EUR0.51
Market Cap
EUR46.17 M
Shares Outstanding
23.15 M
Public Float
21.48 M

Profile

Address
9, rue d'Enghien
Paris Ile-de-France 75010
France
Employees -
Website http://www.maunakeatech.com
Updated 07/08/2019
Mauna Kea Technologies SA is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases. The company engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. Its product, Cellvizio, a probe-based Confocal Laser Endomicroscopy system, provides physicians and researchers high resolution cellular views of tissue inside the body.

Financials

View All

Sacha Loiseau
President, Chief Executive Officer, CFO & Director
Molly K. O'Neill
Director